OSAKA -- Japanese drugmaker Shionogi will work with a company in South Korea to seek authorization there for a treatment for COVID-19 under an agreement announced Friday.
As part of the deal, Seoul-headquartered Ildong Pharmaceutical will be responsible for applying for emergency use authorization for the COVID-19 pill and, if the application is approved, for negotiating government purchases.
